MaxCyte Inc.

NASDAQ: MXCT · Real-Time Price · USD
1.37
-0.04 (-2.84%)
At close: Aug 15, 2025, 3:59 PM
1.35
-1.46%
After-hours: Aug 15, 2025, 05:50 PM EDT

MaxCyte Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
35.75M 37.68M 38.63M 45.6M 45.44M 44.06M 41.29M 38.05M 40.69M 41.25M 44.26M 41.99M 41.49M 38.99M 33.89M 32.26M 28.88M 26.92M
Cost of Revenue
8.3M 8.23M 9.2M 9.56M 8.42M 7.28M 5.8M 4.72M 5.29M 5.04M 5.1M 4.78M 4.35M 4.02M 3.65M 3.33M 3.12M 2.8M
Gross Profit
27.45M 29.45M 29.43M 36.04M 37.02M 36.78M 35.48M 33.33M 35.39M 36.21M 39.16M 37.21M 37.13M 34.97M 30.25M 28.93M 25.76M 24.12M
Operating Income
-52.44M -50.13M -51.14M -46.31M -46.21M -47.34M -48.28M -46.95M -40.71M -36.38M -27.36M -25.57M -20.3M -15.97M -18.19M -15.61M -16.01M -14.44M
Interest Income
8.7M 9.43M 10.14M 10.66M 10.86M 10.83M 10.38M 9.51M 8.2M 6.12M 3.92M 2.05M 702.8K 232.7K 150.7K 80.3K 35.6K 32.2K
Pretax Income
-44.77M -41.79M -41.05M -35.73M -35.43M -36.57M -37.92M -37.45M -32.64M -30.38M -23.57M -23.64M -19.88M -16.04M -19.08M -16.86M -17.28M -15.86M
Net Income
-44.77M -41.79M -41.05M -35.73M -35.43M -36.57M -35.63M -33.22M -28.4M -25.67M -21.06M -23.07M -19.31M -15.95M -19.08M -16.86M -17.28M -15.86M
Selling & General & Admin
55.75M 56.08M 56.3M 57.88M 57.8M 57.67M 57.03M 52.79M 49.87M 47.81M 44.48M 43.51M 41.43M 36.93M 32.24M 27.28M 22.77M 18.67M
Research & Development
22.1M 21.45M 22.23M 23.45M 24.4M 24.45M 23.82M 23.7M 22.76M 21.8M 19.51M 17.17M 14.62M 13.13M 15.44M 16.95M 18.69M 19.58M
Other Expenses
2.04M 2.04M 2.04M 1.02M 239.1M 239.1M 240.01M 240.89M 1.67M 2.17M 1.7M 1.27M 1.39M 889.2K 441.9K n/a n/a n/a
Operating Expenses
78.79M 78.48M 79.47M 82.36M 83.23M 84.12M 83.76M 80.29M 76.11M 72.59M 66.52M 62.78M 57.43M 50.94M 48.44M 44.54M 41.77M 38.56M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a 10.9K 126.9K 126.9K 126.9K 116K 289K 302.2K 1.04M 1.33M 1.3M 1.45M
Selling & Marketing Expenses
24.16M 24.99M 26.66M 27.38M 28.22M 28.04M 26.98M 25.16M 22.62M 21.11M 18.65M 17.37M 16.07M 14.05M 13M 11.31M 10.14M 9.07M
Cost & Expenses
88.19M 87.81M 89.77M 91.91M 91.65M 91.4M 89.57M 85M 81.4M 77.63M 71.62M 67.56M 61.78M 54.96M 52.08M 47.87M 44.89M 41.36M
Income Tax Expense
n/a n/a n/a n/a n/a 1.58B 1.58B 1.58B 1.58B -4.72M -2.51M -570.5K -570.5K -83.2K 18.4K 28.8K 35.6K 27K
Shares Outstanding (Basic)
106.4M 105.95M 104.85M 105.11M 104.64M 104.09M 103.7M 103.45M 103.06M 102.85M 102.12M 101.81M 101.43M 101.31M 100.83M 95.66M 84.71M 81M
Shares Outstanding (Diluted)
106.4M 105.95M 104.85M 105.11M 104.64M 104.09M 103.7M 103.45M 103.06M 102.85M 102.12M 101.81M 101.43M 101.31M 100.83M 95.66M 84.71M 81M
EPS (Basic)
-0.43 -0.4 -0.39 -0.34 -0.34 -0.35 -0.34 -0.32 -0.27 -0.25 -0.21 -0.23 -0.19 -0.17 -0.22 -0.2 -0.21 -0.21
EPS (Diluted)
-0.43 -0.4 -0.39 -0.34 -0.34 -0.35 -0.34 -0.32 -0.27 -0.25 -0.21 -0.23 -0.19 -0.17 -0.22 -0.2 -0.21 -0.21
EBITDA
-45.61M -45.42M -46.41M -42.03M -41.92M -40.51M -39.27M -36.17M -30.26M -28.97M -22.72M -23.37M -18.48M -14.37M -16.75M -14.3M -14.77M -13.27M
EBIT
-50.55M -50.16M -51.2M -46.39M -46.29M -47.4M -48.3M -45M -38.76M -34.43M -25.41M -25.57M -20.24M -15.91M -18.12M -15.53M -15.98M -14.41M
Depreciation & Amortization
4.46M 4.26M 4.32M 4.36M 4.38M 4.32M 4.17M 3.99M 3.62M 3.14M 2.66M 2.16M 1.82M 1.6M 1.42M 1.29M 1.21M 1.14M